In conclusion, AFAP1-AS1 promoted chemotherapy resistance by supressing miR-139-5p expression and promoting RRM2/EGFR/AKT signaling pathway in NSCLC cells. The gene discussed is RRM2; the disease is non-small cell lung carcinoma.